# ZNF706

## Overview
ZNF706 is a gene that encodes the zinc finger protein 706, a member of the C2H2-type zinc finger protein family, which is the most prevalent class of DNA-binding transcription factors in the human genome. The protein is characterized by its ability to bind specific DNA sequences, thereby playing a crucial role in the regulation of gene expression. Structurally, zinc finger protein 706 is composed of 76 amino acids and features a β-β-α zinc finger fold with two zinc-binding sites, which are essential for its DNA-binding function (Colombo2013Expression). Functionally, ZNF706 is involved in various cellular processes, including cell growth, proliferation, apoptosis, and intracellular signal transduction, particularly through its participation in the MAPK signaling pathway (Colombo2013Expression). The protein's expression is notably sex-specific in human lymphoblastoid cell lines, and it has been implicated in carcinogenesis and other diseases, such as rheumatoid arthritis and male fertility issues (Charpin2013New; Prakash2021Comparative; Colombo2013Expression). Ongoing research aims to further elucidate its biological roles and potential as a therapeutic target.

## Structure
The ZNF706 protein is a member of the zinc finger family, characterized by its involvement in gene expression control through DNA binding. The protein is composed of 76 amino acids and has a molecular weight of approximately 12 kDa, including a 6xHis tag used for purification (Colombo2013Expression). 

The secondary structure of ZNF706 includes 35% α-helices, 10% β-strands, 27% turns, and 28% random coils, as determined by circular dichroism spectroscopy (Colombo2013Expression). Homology modeling has revealed that ZNF706 possesses a β-β-α zinc finger fold, with two zinc-binding sites. This structure is characterized by a β-hairpin and an α-helical region, each providing zinc-coordinating residues, and is dominated by metal-ligand interactions typical of zinc finger proteins (Colombo2013Expression).

The protein's tertiary structure includes two cysteine residues, Cys41 and Cys44, which are in close proximity but do not form a disulfide bridge due to their distance (Colombo2013Expression). The N-terminal 9 residues are unique to ZNF706 and were not included in the structural prediction due to the absence of a suitable template (Colombo2013Expression). The study of ZNF706's structure is ongoing, with potential implications for understanding its role in carcinogenesis (Colombo2013Expression).

## Function
The ZNF706 gene encodes a zinc finger protein that is involved in the regulation of gene expression by binding to specific DNA sequences. This protein is part of the C2H2-type zinc finger family, which is the most common type of DNA-binding site among transcription factors in the human genome. These proteins typically recognize 3-4 base pairs of DNA and are involved in various biological processes, including the recognition of RNA and other proteins (Colombo2013Expression).

ZNF706 is implicated in several cellular processes such as cell growth, proliferation, apoptosis, and intracellular signal transduction. It participates in the MAPK signaling pathway regulation, which is crucial for controlling gene expression in eukaryotic cells (Colombo2013Expression). The protein's activity is often localized in the nucleus, where it interacts with DNA and other nuclear proteins, influencing transcriptional regulation (Colombo2013Expression).

Although the specific functions of ZNF706 in healthy human cells are not well-documented, it is known to have a sex-specific expression pattern in human lymphoblastoid cell lines. The protein's potential role in carcinogenesis and its interactions with other biological molecules are areas of ongoing research, which could aid in drug design and therapeutic applications (Colombo2013Expression).

## Clinical Significance
ZNF706 has been implicated in various diseases, particularly in the context of cancer and rheumatoid arthritis. In cancer, ZNF706 is notably upregulated in laryngeal squamous cell carcinoma and breast cancer, suggesting its involvement in tumor progression and carcinogenesis (Świtnicki2016PINCAGE:; Reis2009Gene). The gene is also associated with copy number amplifications in gastric cancer, indicating a potential role in cancer development (Colombo2013Expression). In breast cancer, ZNF706's expression correlates with gene body and promoter methylation levels, which differ between progressing and non-progressing tumors, highlighting its potential as a biomarker for cancer progression (Świtnicki2016PINCAGE:).

In rheumatoid arthritis, ZNF706 is recognized by autoantibodies in early RA patients, suggesting its potential as a diagnostic marker, especially in patients who lack traditional markers like anti-cyclic citrullinated protein antibodies and rheumatoid factor (Charpin2013New). Additionally, in the context of fertility, ZNF706 is significantly downregulated in low-fertile bull spermatozoa, indicating a possible role in male fertility (Prakash2021Comparative). These findings underscore the gene's clinical significance across various conditions.


## References


[1. (Świtnicki2016PINCAGE:) Michał P. Świtnicki, Malene Juul, Tobias Madsen, Karina D. Sørensen, and Jakob S. Pedersen. Pincage: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification. Bioinformatics, 32(9):1353–1365, January 2016. URL: http://dx.doi.org/10.1093/bioinformatics/btv758, doi:10.1093/bioinformatics/btv758. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/bioinformatics/btv758)

[2. (Prakash2021Comparative) Mani Arul Prakash, Arumugam Kumaresan, John Peter Ebenezer Samuel King, Pradeep Nag, Ankur Sharma, Manish Kumar Sinha, Elango Kamaraj, and Tirtha Kumar Datta. Comparative transcriptomic analysis of spermatozoa from high- and low-fertile crossbred bulls: implications for fertility prediction. Frontiers in Cell and Developmental Biology, May 2021. URL: http://dx.doi.org/10.3389/fcell.2021.647717, doi:10.3389/fcell.2021.647717. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.647717)

[3. (Charpin2013New) Caroline Charpin, Fanny Arnoux, Marielle Martin, Eric Toussirot, Nathalie Lambert, Nathalie Balandraud, Daniel Wendling, Elisabeth Diot, Jean Roudier, and Isabelle Auger. New autoantibodies in early rheumatoid arthritis. Arthritis Research &amp; Therapy, July 2013. URL: http://dx.doi.org/10.1186/ar4255, doi:10.1186/ar4255. This article has 20 citations.](https://doi.org/10.1186/ar4255)

[4. (Colombo2013Expression) Jucimara Colombo, Paola Jocelan Scarin Provazzi, Marilia Freitas Calmon, Lilian Campos Pires, Nathália Campos Rodrigues, Paulo Petl, Marcelo Andrés Fossey, Fátima Pereira de Souza, Fernanda Canduri, and Paula Rahal. Expression, purification and molecular analysis of the human znf706 protein. Biological Procedures Online, September 2013. URL: http://dx.doi.org/10.1186/1480-9222-15-10, doi:10.1186/1480-9222-15-10. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1480-9222-15-10)

[5. (Reis2009Gene) Reis. Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncology Reports, July 2009. URL: http://dx.doi.org/10.3892/OR_00000268, doi:10.3892/or_00000268. This article has 82 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/OR_00000268)